Chances are that you or someone you know has faced a cancer diagnosis.  It’s also likely that after a diagnosis, the possibility of participating in clinical trials was highlighted. For… Read more

Patient enrollment for clinical trials can be a challenging task especially if the patients are dealing with a chronic illness. Dialysis patients in particular are a population that need a… Read more

Over the next few years, the patents for many therapeutic biologics will expire, allowing drug manufacturers to request US Food and Drug Administration (FDA) approval for biosimilars, medical products which… Read more

New study sheds light on the factors for high turnover of principal investigators in FDA-regulated clinical trials. The U.S. biopharmaceutical industry is a global leader in the development of innovative… Read more

Sometimes you experience great service. An interaction that leaves you thinking – WOW, that person really loves their job! A problem you had solved in a way that left you… Read more

By Amy Young, VP and General Manager, DaVita Clinical Research Drug development is expensive and complicated. Those facts seem to ring more true each year. According to the Tufts Center… Read more

Getting people with Chronic Kidney Disease (CKD) in on the ground floor. At DaVita Clinical Research, our specialty is performing research in people with chronic kidney disease (CKD). From the… Read more

 The study case report form (CRF) is arguably the most important clinical study document. While the protocol drives the conduct of the study, the CRF dictates the data to be… Read more

Let’s talk adaptive trial design, particularly as it pertains to early clinical research right now.  Both large and small pharmaceutical companies see the potential to shorten development timelines using adaptive… Read more

For years, we relied on simple questionnaires to conduct trial feasibility: identify sites likely to enroll, send out a questionnaire along with inclusion/exclusion (I/E) criteria, and request each site to… Read more